455 related articles for article (PubMed ID: 22236539)
41. Seroepidemiology of Toxoplasma gondii infection in human adults from three rural communities in Durango State, Mexico.
Alvarado-Esquivel C; Cruz-Magallanes HM; Esquivel-Cruz R; Estrada-Martínez S; Rivas-González M; Liesenfeld O; Martínez-García SA; Ramírez E; Torres-Castorena A; Castañeda A; Dubey JP
J Parasitol; 2008 Aug; 94(4):811-6. PubMed ID: 18576838
[TBL] [Abstract][Full Text] [Related]
42. Seroprevalence and risk factors for Toxoplasmosis in HIV infected and non-infected individuals in Bahir Dar, Northwest Ethiopia.
Walle F; Kebede N; Tsegaye A; Kassa T
Parasit Vectors; 2013 Jan; 6(1):15. PubMed ID: 23324409
[TBL] [Abstract][Full Text] [Related]
43. [Evaluation of serological results of patients with suspected Toxoplasmosis admitted to the medical parasitology laboratory of Celal Bayar University Hospital between 2006-2010].
Bölük S; Ozyurt BC; Girginkardeşler N; Kilimcioğlu AA
Turkiye Parazitol Derg; 2012; 36(3):137-41. PubMed ID: 23169155
[TBL] [Abstract][Full Text] [Related]
44. Seroprevalence and sociodemographic characteristics of Toxoplasma gondii infection in patients with psychiatric disorders in Malaysia.
Maisarah A; Mohamad S; Husain M; Abdullah S; Noordin R
Acta Trop; 2024 Jul; 255():107241. PubMed ID: 38710263
[TBL] [Abstract][Full Text] [Related]
45. Seroprevalence of anti-Toxoplasma IgG and IgM among individuals who were referred to medical laboratories in Mazandaran province, northern Iran.
Sharif M; Daryani A; Ebrahimnejad Z; Gholami S; Ahmadpour E; Borhani S; Lamsechi N
J Infect Public Health; 2016; 9(1):75-80. PubMed ID: 26159578
[TBL] [Abstract][Full Text] [Related]
46. Seroprevalence of toxoplasmosis and risk factors of Toxoplasma gondii infection among pregnant women in Sri Lanka: a cross sectional study.
Iddawela D; Vithana SMP; Ratnayake C
BMC Public Health; 2017 Dec; 17(1):930. PubMed ID: 29202747
[TBL] [Abstract][Full Text] [Related]
47. Seroprevalence of Toxoplasma antibodies among individuals tested at hospitals and private laboratories in Beirut.
Bouhamdan SF; Bitar LK; Saghir HJ; Bayan A; Araj GF
J Med Liban; 2010; 58(1):8-11. PubMed ID: 20358853
[TBL] [Abstract][Full Text] [Related]
48. Seroprevalence and risk factors of Toxoplasma gondii infection in humans in East Hararghe Zone, Ethiopia.
Tilahun B; Hailu Y; Tilahun G; Ashenafi H; Vitale M; Di Marco V; Gebremedhin EZ
Epidemiol Infect; 2016 Jan; 144(1):64-71. PubMed ID: 26072985
[TBL] [Abstract][Full Text] [Related]
49. Increased Risk of
Yu Y; Guo D; Qu T; Zhao S; Xu C; Wang L; Wang Z; Fu H; Zhang X; Zhou N
Biomed Res Int; 2020; 2020():2539482. PubMed ID: 33083457
[TBL] [Abstract][Full Text] [Related]
50. IgG avidity antibodies against Toxoplasma gondii in high risk females of reproductive age group in India.
Siddiqui N; Shujatullah F; Khan HM; Rabbani T; Khan PA
Korean J Parasitol; 2014 Oct; 52(5):487-91. PubMed ID: 25352696
[TBL] [Abstract][Full Text] [Related]
51. Seroprevalence of Toxoplasma gondii Infection Among Β-Thalassemia Major Pediatric Population: Implications for Transfusion Transmissible Toxoplasmosis.
El-Tantawy N; Darwish A; Eissa E
Pediatr Infect Dis J; 2019 Mar; 38(3):236-240. PubMed ID: 29762364
[TBL] [Abstract][Full Text] [Related]
52. Seroprevalence and risk factors of Toxoplasma gondii infection in pregnant women from Bobo Dioulasso, Burkina Faso.
Bamba S; Cissé M; Sangaré I; Zida A; Ouattara S; Guiguemdé RT
BMC Infect Dis; 2017 Jul; 17(1):482. PubMed ID: 28693432
[TBL] [Abstract][Full Text] [Related]
53. Seroprevalence and associated risk factors of Toxoplasma gondii infection in the Korean, Manchu, Mongol and Han ethnic groups in eastern and northeastern China.
Zhang XX; Zhao Q; Shi CW; Yang WT; Jiang YL; Wei ZT; Wang CF; Yang GL
Epidemiol Infect; 2016 Jul; 144(9):2018-24. PubMed ID: 26833424
[TBL] [Abstract][Full Text] [Related]
54. Seroprevalence and Associated Risk Factors for Toxoplasma gondii Infection in Healthy Blood Donors: A Cross-Sectional Study in Sonora, Mexico.
Alvarado-Esquivel C; Rascón-Careaga A; Hernández-Tinoco J; Corella-Madueño MA; Sánchez-Anguiano LF; Aldana-Madrid ML; Velasquez-Vega E; Quizán-Plata T; Navarro-Henze JL; Badell-Luzardo JA; Gastélum-Cano JM; Liesenfeld O
Biomed Res Int; 2016; 2016():9597276. PubMed ID: 27446960
[TBL] [Abstract][Full Text] [Related]
55. Toxoplasma gondii presence in women with spontaneous abortion in Yucatan, Mexico.
Vado-Solís IA; Suárez-Solís V; Jiménez-Delgadillo B; Zavala-Velázquez JE; Segura-Correa JC
J Parasitol; 2013 Apr; 99(2):383-5. PubMed ID: 22924922
[TBL] [Abstract][Full Text] [Related]
56. Immunological status against Toxoplasma gondii in non-cat owners from an endemic region of Mexico.
Jiménez-Coello M; Guzmán-Marín E; Ortega-Pacheco A; Acosta-Viana KY
Vector Borne Zoonotic Dis; 2011 Aug; 11(8):1057-61. PubMed ID: 21254942
[TBL] [Abstract][Full Text] [Related]
57. SEROPREVALENCE OF TOXOPLASMA GONDII INFECTION AND ITS AS- SOCIATED RISK FACTORS IN NEUROPSYCHIATRIC PATIENTS IN JAZAN PROVINCE, SAUDI ARABIA.
Zaki WM; Hofdi RY; Shebiley AA; Saadi ZA; Ageel AH
J Egypt Soc Parasitol; 2016 Dec; 46(3):467-474. PubMed ID: 30230742
[TBL] [Abstract][Full Text] [Related]
58. [Evaluation of the toxoplasmosis seroprevalence in pregnant women and creating a diagnostic algorithm].
Mumcuoglu I; Toyran A; Cetin F; Coskun FA; Baran I; Aksu N; Aksoy A
Mikrobiyol Bul; 2014 Apr; 48(2):283-91. PubMed ID: 24819265
[TBL] [Abstract][Full Text] [Related]
59. Association of the presence of residual anti-Toxoplasma gondii IgM in pregnant women and their respective family groups in Miracema, Northwest Rio de Janeiro, Brazil.
Ribeiro AC; Mutis MS; Fernandes O
Mem Inst Oswaldo Cruz; 2008 Sep; 103(6):591-4. PubMed ID: 18949330
[TBL] [Abstract][Full Text] [Related]
60. [Seroprevalence and risk factors of
Xie YQ; He MZ; Zhang WH
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2020 Jul; 32(6):635-639. PubMed ID: 33325201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
